Medical News

Medical News2017-05-20T17:58:14+03:00

Medical news                  

Отворено писмо от името на Сдружение Клуб Млад Онколог България

В това отворено писмо бихме искали да изложим становището на лекарите медицински онколози, членуващи в Клуб Млад Онколог относно наскоро въведените лимити за медицински дейности и лекарства за онкологично болни пациенти. Противно нa тезата, че [...]

By |April 4th, 2015|Categories: Uncategorized|Comments Off on Отворено писмо от името на Сдружение Клуб Млад Онколог България

Approval concerns filgrastim-sndz intended for patients with cancer who receive myelosuppressive chemotherapy

Date: 10 Mar 2015 Topic: Palliative and supportive care On 6 March 2015 the US Food and Drug Administration (FDA) approved filgrastim-sndz (Zarxio), the first biosimilar product approved in the United States. Sandoz Inc.’s Zarxio [...]

By |March 25th, 2015|Categories: Uncategorized|Comments Off on Approval concerns filgrastim-sndz intended for patients with cancer who receive myelosuppressive chemotherapy

Whole Genome Sequencing of Pancreatic Ductal Adenocarcinomas

Pancreatic cancer mutational landscape Date: 04 Mar 2015 Topic: Translational research / Gastrointestinal cancers The researchers performed whole-genome sequencing and copy number variation analysis of 100 samples to reveal mutational landscape of pancreatic ductal adenocarcinomas. [...]

By |March 12th, 2015|Categories: Uncategorized|Comments Off on Whole Genome Sequencing of Pancreatic Ductal Adenocarcinomas

New research reveals a connection between ccRCC and exposure to an ingredient in some herbal remedies

Date: 03 Nov 2014 Topic: Genitourinary cancers / Translational research New research by the international Cancer Genomics of the Kidney consortium (CAGEKID) reveals an important connection between clear cell renal cell cancer (ccRCC) and exposure [...]

By |November 10th, 2014|Categories: Uncategorized|Comments Off on New research reveals a connection between ccRCC and exposure to an ingredient in some herbal remedies

New findings suggest why patients with early-stage tumours and EGFR mutations have worse outcomes with erlotinib

Date: 30 Oct 2014 Topic: Translational research / Lung and other thoracic tumours / Anticancer agents & Biologic therapy David Carbone David Carbone Mutations in the epidermal growth factor receptor (EGFR) are the most common [...]

By |November 10th, 2014|Categories: Uncategorized|Comments Off on New findings suggest why patients with early-stage tumours and EGFR mutations have worse outcomes with erlotinib

Novel Immunotherapy Vaccine May Decrease Recurrence in HER2 Positive Breast Cancer Patients

Women who received trastuzumab as part of standard treatment show greatest benefit Date: 10 Sep 2014Topic: Breast cancer / Immuno-oncology A new breast cancer vaccine candidate, GP2, provides further evidence of the potential of immunotherapy [...]

By |September 23rd, 2014|Categories: Uncategorized|Comments Off on Novel Immunotherapy Vaccine May Decrease Recurrence in HER2 Positive Breast Cancer Patients
Go to Top